LINC00266-1

Across TCGA pan-cancer cohorts, LINC00266-1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC00266-1’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where LINC00266-1 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00266-1 is over-expressed in tumor, although a few such as PAAD and UCEC show the opposite, repressed pattern.

PAAD, UCEC, and KIRP are the cancer types where LINC00266-1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00266-1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Male	All	−0.065	.005	2	view →
UCEC	All	All	−0.063	.004	2	view →
KIRP	All	All	−0.030	.015	1	view →
KIRC	All	All	−0.020	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC00266-1–PAAD

Open the PAAD breakdown →